Freedman Financial Associates, Inc. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 288 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
Freedman Financial Associates, Inc. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2022$10,000
-37.5%
1500.0%0.01%
-36.4%
Q4 2021$16,000
+6.7%
1500.0%0.01%0.0%
Q3 2021$15,000
+15.4%
1500.0%0.01%
+10.0%
Q2 2021$13,000
-13.3%
1500.0%0.01%
-16.7%
Q1 2021$15,000
-11.8%
1500.0%0.01%
-20.0%
Q4 2020$17,0001500.02%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 380,012$42,618,0008.86%
DAFNA Capital Management LLC 206,911$23,205,0006.90%
Casdin Capital, LLC 1,550,000$173,833,0005.15%
Eagle Health Investments LP 62,060$6,960,0004.45%
SIB LLC 54,912$6,158,0004.11%
CADIAN CAPITAL MANAGEMENT, LP 1,059,450$118,817,0003.05%
Tri Locum Partners LP 73,906$8,289,0003.01%
Integral Health Asset Management, LLC 85,000$9,533,0002.84%
MAKENA CAPITAL MANAGEMENT LLC 38,924$4,365,0002.42%
Rock Springs Capital Management LP 842,000$94,430,0002.00%
View complete list of BLUEPRINT MEDICINES CORP shareholders